Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
November 22, 2021
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force
Kiat Hon Tony Lim, Hwai Loong Kong, Kenneth Tou En Chang, et al.
Journal of Hepatology
|
November 1, 2019
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Journal of Hepatology
|
June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Liver Cancer
|
September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial
Stephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Plos One
|
March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
Pierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Scientific Reports
|
January 20, 2017
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Sarah B Ng, Clarinda Chua, Matthew Ng, et al.
International Journal of Cancer
|
April 13, 2022
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
Matthew Ng, Sylvia Chen, Whee Sze Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Thomas Yau, Vittorina Zagonel, Armando Santoro, et al.
Journal of Hepatology
|
May 29, 2021
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Masatoshi Kudo, Ana Matilla, Armando Santoro, et al.
Therapeutic Advances in Medical Oncology
|
December 20, 2019
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Asia-Pacific Journal of Clinical Oncology
|
November 22, 2021
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force
Kiat Hon Tony Lim, Hwai Loong Kong, Kenneth Tou En Chang, et al.
Journal of Hepatology
|
November 1, 2019
Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Journal of Hepatology
|
June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
Thomas Yau, Chiun Hsu, Tae-You Kim, et al.
Liver Cancer
|
September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial
Stephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Plos One
|
March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
Pierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Scientific Reports
|
January 20, 2017
Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
Sarah B Ng, Clarinda Chua, Matthew Ng, et al.
International Journal of Cancer
|
April 13, 2022
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects
Matthew Ng, Sylvia Chen, Whee Sze Ong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
Thomas Yau, Vittorina Zagonel, Armando Santoro, et al.
Journal of Hepatology
|
May 29, 2021
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis
Masatoshi Kudo, Ana Matilla, Armando Santoro, et al.
Therapeutic Advances in Medical Oncology
|
December 20, 2019
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
Shukui Qin, Stephen Lam Chan, Wattana Sukeepaisarnjaroen, et al.
Page
of 11